Explore the categories so you can find more about your search.
Categorie > Bipolar
Some Women With Bipolar Depression Benefit From Bright Light
Categorie : BipolarBright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. Researchers from the University of Pittsburgh School of Medicine's Western Psychiatric Institute and Clinic studied nine women with bipolar disorder to examine the effe ...
read more
Mon Jan 2008
Epilepsy, Bipolar Drug To Recommend Genetic Test For Patients Of Asian Ancestry
Categorie : BipolarManufacturers of carbamazepine (Carbatrol, Equetro, Tegretol), a drug used for the treatment of epilepsy, bipolar disorder, and neuropathic pain, have agreed to advise in their labeling that patients of Asian ancestry first have a genetic test before starting treatment. A number of people of Asian ...
read more
Fri Dec 2007
Outcomes In Bipolar Disorder May Be Improved By Stable Sleep Patterns And Regular Routines
Categorie : BipolarBipolar disorder, commonly known as manic-depressive disorder, is highly influenced by the circadian system - the body's internal clock - and a specific kind of psychotherapy may help decrease irregularities in the circadian system that can trigger key symptoms of bipolar disorder, according to a st ...
read more
Wed Dec 2007
Gender-Related Brain Differences In Early Onset Mental Illness
Categorie : BipolarPuberty may have an impact on areas of the brain that contribute to bipolar disorder or schizophrenia in youth, according to a study presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP).Researchers studying the brains of youth with bipolar disorder (also known as ...
read more
Wed Dec 2007
Pregnant Women At Risk Of Bipolar Recurrence With Interruption Of Medication
Categorie : BipolarWomen with bipolar disorder who stop taking their medication - such as lithium, antipsychotics and anticonvulsants prescribed as mood stabilizers - before or shortly after becoming pregnant appear to be much more likely to suffer a recurrence of the disorder, according to a study reported in the Dec ...
read more
Wed Dec 2007
Local Charity Soldiers Of Love Launches Peer Specialist Program To Aid Mental Health Crisis In New Orleans
Categorie : BipolarLocal non-profit organization Soldiers of Love is partnering with the Depression and Bipolar Support Alliance (DBSA) to launch a peer specialist training program to help mitigate the mental health crisis in New Orleans. The training program is an innovative concept for treating patients with mental ...
read more
Fri Dec 2007
Kids With Bipolar Disorder More Aware Of Facial Expressions
Categorie : BipolarChildren with bipolar disorder respond differently to facial expressions than children without psychiatric disorders, according to a new study led by a Bradley Hospital researcher.These findings provide additional insight into the neurobiology of pediatric bipolar disorder. The study is published in ...
read more
Wed Nov 2007
Schering-Plough Announces Asenapine NDA Accepted For Filing By The U.S. FDA
Categorie : BipolarSchering-Plough Corporation (NYSE: SGP) announced that the U.S. Food and Drug Administration (FDA) recently accepted the filing for review of the New Drug Application (NDA) for asenapine, a fast-dissolving, sublingual tablet. Schering-Plough is seeking marketing approval from the FDA for the treatme ...
read more
Mon Nov 2007
A New Proposal For Classifying Mood Swings
Categorie : BipolarA group of Spanish researchers headed by Professor Vieta (University of Barcelona) has made a new proposal for classifying mood swings in the current issue of Psychotherapy and Psychosomatics. Although there is a great heterogeneity of depressive states in bipolar patients, there is only one definit ...
read more
Wed Nov 2007
Abilify(R) (Aripiprazole) Supplemental New Drug Application For Bipolar I Disorder Pediatric Patients Accepted For Priority Review By FDA
Categorie : BipolarOtsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted a Priority Review to the supplemental New Drug Application (sNDA) of the atypical antipsychotic ABILIFYŽ (aripiprazole) for t ...
read more
Wed Nov 2007
Volunteers Sought For Stanford Studies Of Bipolar Disorder
Categorie : BipolarResearchers at the Stanford University School of Medicine are seeking volunteers for several research studies on bipolar disorder, which affects more than 10 million American adults. The illness typically requires lifelong treatment, and researchers have been studying which medications are the most ...
read more
Sat Nov 2007
Repligen Reports Positive Phase 2a Clinical Trial Results Of RG2417 For Symptoms Of Bipolar Disorder
Categorie : BipolarRepligen Corporation (Nasdaq: RGEN) announced positive results from a Phase 2a clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar disorder. This was a multi-center study in which 84 patients received either RG2417 or a placebo twice a day for six-weeks. Patients in t ...
read more
Sat Nov 2007
Lifespan In Worms Dramatically Increased By Drug Commonly Used To Treat Bipolar Disorder
Categorie : BipolarNematode worms treated with lithium show a 46 percent increase in lifespan, raising the tantalizing question of whether humans taking the mood affecting drug are also taking an anti-aging medication. Results of the Buck Institute study, led by faculty member Gordon J. Lithgow, PhD, are currently pub ...
read more
Sat Nov 2007
Misconceptions About Bipolar Disorder Explained, From The Harvard Health Letter
Categorie : BipolarPortrayals of bipolar disorder seem to be cropping up everywhere -- in the news, in movies, and on television. The November 2007 issue of the Harvard Health Letter dispels some myths and misunderstandings about this condition. Bipolar disorder is difficult to diagnose, and it often gets confused ...
read more
Sat Nov 2007
FDA Issues Approvable Letter For Stavzor? Delayed Release Valproic Acid Capsules
Categorie : BipolarNoven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter related to the New Drug Application (NDA) for Stavzor? (delayed release valproic acid capsules) in 125mg, 250mg and 500mg strengths. [click link for full article] ...
read more
Sat Nov 2007
"Wake-Up Pill" Under Study To Treat Patients With Bipolar Disorder
Categorie : BipolarA preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with bipolar disorder. At least 44 percent of the participants in the study reported improved symptoms, a noteworthy improvemen ...
read more
Sun Oct 2007
Severe Mental Illness In Mothers Can Affect Long-Term Health And Development Of Children
Categorie : BipolarBabies' early experiences with a mother suffering from severe mental illness, such as schizophrenia, other psychotic disorders, bipolar disorder or severe major depression disorder may affect their future health and development. Dr. Susan Pawlby, of the Institute of Psychiatry in London, emp ...
read more
Sun Oct 2007
FDA Issues Approvable Letter For Stavzor™ Delayed Release Valproic Acid Capsules
Categorie : BipolarNoven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter related to the New Drug Application (NDA) for Stavzor™ (delayed release valproic acid capsules) in 125mg, 250mg and 500mg strengths. [click link for full articl ...
read more
Sun Oct 2007
Discovering A Seasonal Pattern In Bipolar Disorder Symptoms May Have Implications For Better Management
Categorie : BipolarApproximately one fifth of people with bipolar disorder, mostly those with bipolar II, find their symptoms wax and wane with the seasons. Benito Mussolini was a prime example. In her biography of the Italian dictator Margarita Sarfati wrote: "He was quiet for months on end. But then came the trou ...
read more
Sun Oct 2007
AACAP Meeting Offers Latest Science On Mental Illness In Children And Adolescents
Categorie : BipolarThe American Academy of Child and Adolescent Psychiatry (AACAP), convenes its 54th Annual Meeting in Boston, Massachusetts on October 23-28, 2007. Experts will present on bipolar disorder, ADHD, substance abuse, autism, bullying, prevention, trauma, and neuroimaging. The meeting is free for cred ...
read more
Sun Oct 2007
Custom Search